Log in
Enquire now
iBio

iBio

A biotechnology company that develops and markets pharmaceutical products. It was founded in 2008 and is located in New York City.

OverviewStructured DataIssuesContributors

Contents

ibioinc.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Biosecurity
Biosecurity
Technology
Technology
Biology
Biology
Location
San Diego
San Diego
0
New York City
New York City
Bryan, Texas
Bryan, Texas
0
New York
New York
B2X
B2B
B2B
0
CEO
‌
Thomas Isett
0
Founder
‌
Robert B. Kay
Pitchbook URL
pitchbook.com/profiles.../51067-00
Legal Name
iBio, Inc.
Number of Employees (Ranges)
11 – 50
Email Address
info@ibioinc.com
Phone Number
+19794460027
Full Address
600 Madison Avenue Suite 1601 New York, NY 10022
10210 Campus Point Drive Suite 150 San Diego, CA 921210
8800 HSC Pkwy Bryan, TX 778070
CIK Number
1,420,7200
Place of Incorporation
Delaware
Delaware
0
DUNS Number
0106349300
IRS Number
262,797,8130
Founded Date
2008
Total Funding Amount (USD)
13,177,000
Latest Funding Round Date
February 2016
Stock Symbol
IBIO0
Exchange
NYSE MKT
NYSE MKT
0
CFO
‌
Robert M. Lutz
0
NAICS Code
325,4120
CAGE Code
6PZ260
Patents Assigned (Count)
1
Country
United States
United States
0
Headquarters
New York City
New York City
0

Other attributes

Company Operating Status
Active
Contact Page URL
ibioinc.com/contact/
Previous Name
iBioPharma, Inc.0
SIC Code
2,8340
Ticker Symbol
IBIO

iBio is a United States-based biotechnology company with a focus on streamlining the process of making a pharmaceutical product available on the market. It has developed platforms and has manufacturing facilities in Texas which can develop and product medical solutions such as vaccines, biotherapeutics, diagnostic products, and some medical devices.

COVID-19

The company's platform called FastPharming uses technology to expedite the development process for making medical solutions, such as the one necessary for COVID-19 due to the pandemic is has caused. iBio partnered with the Infectious Disease Research Institute (IDRI) to develop a vaccine where the company is set to provide process development and manufacturing services to IDRI, which is in charge of the pre-clinical development of the vaccine and clinical studies overview.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

IBio Expands COVID-19 Vaccine Collaboration - Contract Pharma

https://www.contractpharma.com/contents/view_breaking-news/2020-04-13/ibio-expands-covid-19-vaccine-collaboration/

Web

iBio Joins the Alliance for Biosecurity

https://finance.yahoo.com/news/ibio-joins-alliance-biosecurity-113010899.html

Web

March 20, 2020

References

Find more companies like iBio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.